Once again, continuous glucose monitors (CGMs) and automated insulin delivery systems took most of the headlines, as the leaders in the space keep building on their platforms while challengers continue to enter the fray.
Meanwhile, the industry saw some significant personnel changes, strategy shifts and one major planned separation.
At Drug Delivery Business News, we’ve been covering all of the large developments across the diabetes tech industry. Earlier this year, we released a Diabetes Tech Industry Special Report, sharing the biggest companies and the biggest news in the space. We also have a Medtech Market Report on the CGM industry available for purchase.
